Are microplastics hormone disruptors?

Whether microplastics are hormone disruptors is really two questions. The first is whether the polymer particle itself perturbs endocrine tissue. The second is whether the chemicals riding with the particle (such as plasticizers, bisphenols, brominated flame retardants, sorbed environmental pollutants) do the endocrine work, with the plastic acting mostly as a carrier and reservoir. The literature answers both questions with a qualified yes, but not with equal confidence, and not through the same mechanisms.

Why this matters

Endocrine disruption is not an abstract toxicology category. It maps onto declining sperm counts, rising thyroid disease, altered pubertal timing, gestational complications, and a large fraction of the reproductive health signal that motivates most of the public interest in microplastics in the first place. That public interest was pulled sharply into focus in 2026 by The Plastic Detox, the Netflix documentary from Louie Psihoyos and Josh Murphy that followed six couples with unexplained infertility through a three month plastic reduction experiment and put the endocrine disruption question in front of a mainstream audience.

Human exposure to both the particles and their chemical passengers is already ubiquitous. Polymer fragments have been recovered from blood ^[1], semen ^[2], uterine tissue ^[3], follicular fluid ^[4], lung tissue ^[5], arterial tissue ^[6], feces ^[7], placenta and breast milk^[8], and the accompanying chemicals like bisphenol A, phthalate metabolites, brominated flame retardants are detected in virtually every biomonitoring cohort ever assembled ^[9]. If any part of this exposure is genuinely endocrine-active in humans at current doses, the population level consequences are non-trivial ^[10].

Background: what "endocrine disruption" means here

An endocrine disrupting chemical (EDC) is any exogenous compound that alters hormone synthesis, transport, receptor binding, or clearance in a way that produces an adverse effect. The classic examples associated with plastics are bisphenol A (BPA) and its analogs, phthalate plasticizers such as di-(2-ethylhexyl) phthalate (DEHP), alkylphenols like nonylphenol, and brominated flame retardants such as tetrabromobisphenol A (TBBPA). None of these are the polymer. All of them are added to the polymer during manufacture, or sorb onto it later during environmental aging, and can leach out under biologically relevant conditions ^[11-13]. Every common consumer polymer (e.g., polyethylene, polypropylene, PVC, HDPE, polystyrene) leaks some combination of residual monomers, oligomers, and additives, even in virgin material ^[14].

Microplastics complicate the picture in three ways. They physically carry these chemicals into tissues and lumens where free chemical would not have reached at the same local concentration ^[15-16]. They provide a large surface area for continued sorption from surrounding water, food, or gut contents ^[17]. And when the particles themselves are small enough to be internalized, they trigger cellular responses (such as reactive oxygen species, mitochondrial dysfunction, inflammatory signaling) that overlap mechanistically with the downstream effects of many EDCs ^[18]. The more careful framings in the field now treat microplastics as a diverse contaminant suite rather than a single class of particle, precisely because polymer, additive, and sorbed chemistry travel together and cannot be cleanly separated in real world exposure ^[19]. Any honest answer to "are microplastics hormone disruptors" has to keep those three pathways separate.

The particle as a chemical vector

The simplest story is the vector story. Plastics are chemically rich objects. A polyvinyl chloride microfragment can carry lead-based stabilizers that become bioavailable in fish ^[20]. Marine microplastics leach nonylphenol, BPA, and phthalate esters at measurable rates under body-relevant conditions ^[21-22]. Weathering accelerates all of it: UV exposure, mechanical abrasion, and biofilm colonization chew up polymer chains, expose additive-rich subsurface, and increase both leaching rates and sorption capacity ^[17,23-24].

In cell-based bioassays, leachates from UV-weathered polyethylene, PET, polypropylene, and polystyrene showed cytotoxicity and receptor activity that virgin polymer did not ^[25]. In tire-rubber and PVC leachates, the toxicity profile tracked the chemical fingerprint, not the particle mass ^[26].

Enhanced desorption of persistent organic pollutants from microplastics under gut conditions is roughly thirty times higher than under seawater conditions, meaning that a particle passing through a mammalian intestine releases far more of its bound chemical load than the same particle sitting in the ocean ^[16]. Microplastics have been shown to raise BPA accumulation in zebrafish tissue by a factor of two to three when co-administered, with corresponding neurotoxic effects downstream of the added BPA burden ^[27]. Aged polystyrene sorbs more BPA than fresh polystyrene, and releases it more readily under simulated gastrointestinal conditions ^[28-29]. Cosmetic microbeads carrying tetrabromobisphenol A produced greater developmental effects in zebrafish than TBBPA alone at matched nominal dose ^[30].

None of that says the polymer itself is the endocrine active ingredient. It says the polymer is a very efficient delivery system for compounds that are.

Bisphenol A and the bisphenol chemistry

BPA is the archetype. It is a diphenyl compound synthesized from acetone and phenol, used primarily to make polycarbonate plastic and epoxy resins, and it binds directly to estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and to a lesser degree the androgen and thyroid hormone receptors. Its endocrine profile is not in serious scientific dispute.

What microplastics add is exposure. BPA and its analogs have been quantified in fish muscle and liver at levels that correlate with local microplastic contamination ^[31], in indoor and outdoor air ^[9], in bottled water ^[32], and in fish sampled from northern Taiwanese estuaries alongside phthalates, nonylphenol, and microplastics ^[33]. Human intestinal Caco-2 cells exposed to polystyrene particles across five size classes take up smaller particles preferentially, and co-exposure with BPA alters both particle uptake and cellular toxicity relative to either exposure alone ^[34]. In bivalves, co-exposure to BPA and microplastics produced immunotoxicity and neurotoxicity greater than either alone ^[35]. In freshwater algae, algal exopolymers reduced BPA + polystyrene nanoparticle toxicity only partially, suggesting the two exposures interact rather than simply summing ^[36]. In human blood cells and freshwater snails, polystyrene microplastics showed synergistic genotoxicity with BPA at concentrations where each alone caused little damage ^[37]. And in mice exposed to polystyrene nanoplastics with or without BPA for four weeks, the two together produced thyroid follicular disruption and altered thyroid hormone levels beyond what either produced alone ^[38].

The pattern is consistent across systems: microplastics act as BPA amplifiers. They do not appear to substitute for BPA at the receptor. They change their pharmacokinetics.

Phthalates and DEHP

Phthalates are the plasticizers that keep flexible PVC flexible. DEHP is the most abundant, and the most studied. Their endocrine profile is well characterized independently of plastic particles: anti-androgenic activity in male reproductive development, thyroid hormone perturbation in children, and adipogenic activity that has driven the "obesogen" hypothesis ^[9,39-40]. Their relevance to microplastics is that they are inside the particles, they leach out on physiologically relevant timescales, and they co-occur with plastic exposure everywhere the two have been measured together.

Microplastics release phthalate esters into the mouse gut and cause additive intestinal injury that is not seen with equivalent doses of either alone ^[41]. DEHP leaching from PVC microplastics is strongly temperature-, salinity-, and UV-dependent, and rises substantially under conditions closer to a mammalian body than to seawater ^[42]. So-called biodegradable microplastics leach DEHP more readily than several conventional formulations, undermining the assumption that biodegradability equates to lower chemical release ^[43]. In fish estuarine sampling, phthalate levels track microplastic abundance, and consumption models suggest human exposure through seafood is non-trivial ^[33].

The co-exposure toxicology paints a coherent picture. Polystyrene nanoplastics and phthalate esters produced greater cytotoxicity in human A549 lung cells than either exposure alone. The nanoplastics acted synergistically at low doses and antagonistically at high ones; a hallmark of a carrier effect rather than a shared mechanism ^[44]. In copepods, PET microparticles and DEHP produced greater developmental toxicity in combination ^[45]. In mice, DEHP and microplastics jointly damaged skeletal muscle via oxidative stress and PI3K/AKT/mTOR inhibition ^[46], delayed wound healing ^[47], and induced neuronal apoptosis in the brain through mitochondrial dysfunction ^[48]. In female mice, polystyrene microplastics and DEHP jointly damaged ovarian granulosa cells through DNA damage and necroptosis, again greater than either alone ^[49]. In freshwater bass, DEHP worsened polystyrene nanoplastic-induced histological damage and gut microbiome disruption ^[50].

Two observations sit on top of this. First, the alternative plasticizers marketed as safer DEHP replacements have measurable endocrine disrupting activity in vitro, so substitution alone does not solve the additive problem ^[51]. Second, the vector logic extends: microplastics change how phthalates arrive at tissue, not just how much arrives.

Thyroid effects

Thyroid biology is a useful test case for the additive versus particle question, because both categories of contaminant hit the same axis.

On the additive side, meta-analyses of pediatric cohorts show that urinary phthalate metabolites are consistently associated with elevated T3 and depressed total T4 in children and adolescents, with dose response patterns supporting a real thyroid disrupting effect at population exposures ^[39]. Umbrella reviews of BPA, phthalate, and PFAS exposure similarly rank thyroid dysfunction among the more consistently supported endocrine outcomes at ambient exposure levels ^[9,52].

On the particle side, polystyrene microplastics enhanced the developmental thyroid toxicity of synthetic phenolic antioxidants in zebrafish embryos, shifting thyroid hormone levels and downstream metabolism at doses of BHA that were subclinical on their own ^[53]. Porous microplastics amplified polychlorinated biphenyl induced thyroid disruption in juvenile Japanese flounder ^[54]. Polystyrene nanoplastics and polybrominated diphenyl ethers acted jointly on zebrafish embryos to produce greater developmental and thyroid effects than either exposure alone ^[55]. In mice, four weeks of polystyrene nanoplastic exposure produced dose-dependent thyroid histological damage and shifts in thyroid hormones, and co-exposure with BPA compounded the effect ^[38].

The particle only signal on the thyroid is real but modest. The particle plus chemical signal is larger and more consistent across models. Reviews focused specifically on the endocrine disrupting effects of nanoplastic exposure treat thyroid disruption as an emerging but still preclinical signal, one where mechanism is clearer than epidemiology ^[52,56].

The brominated flame retardants deserve their own note in this section. TBBPA is a structural analog of BPA with weaker but non-zero estrogenic and stronger thyroid disrupting activity. Microplastics increase TBBPA accumulation in commercial clams to levels that raise food safety concerns ^[57]. Polyethylene microplastics and TBBPA together altered oxidative and endocrine biomarkers in freshwater shrimp ^[58]. Cosmetic microbeads adsorb TBBPA and enhance its bioavailability to zebrafish ^[30]. In human intestinal Caco-2 cells and gut microbiota simulations, microplastic + TBBPA co-exposure produced effects on barrier integrity and microbial composition that TBBPA alone did not ^[59]. Fish cell line work shows co-exposure toxicity that individual exposures did not predict ^[60]. And human serum albumin, the main protein carrier for many small molecule EDCs, binds TBBPA less effectively in the presence of polystyrene nanoplastics; a mechanism by which particles could shift the free-to-bound fraction of a circulating hormone active chemical, indirectly changing its bioactivity ^[61].

Estrogenic activity, receptor binding, and the receptor-active fraction

Estrogenic activity is where the "polymer itself" question is most tractable, because assays exist for direct receptor binding. In UV-weathered leachates from four common polymers, cell based bioassays showed cytotoxicity and receptor activation (including estrogen-receptor-relevant signals) that virgin polymer did not produce, and that scaled with weathering time ^[25]. Marine microplastics and mesoplastics leach endocrine disrupting chemicals under common life stress conditions at levels detectable in yeast-based estrogen bioassays ^[22]. Butyl octyl phthalate, a leachable plasticizer, interacts directly with ERα in MCF-7 breast cancer cells and promotes proliferation ^[62]. Polystyrene microplastics amplified the estrogenic effects of 17α-ethynylestradiol in male marine medaka; meaning the same estrogen dose produced a stronger endocrine effect when microplastics were in the water ^[63].

The important dissent here comes from direct receptor binding assays. When polystyrene micro- and nanoplastics are tested in vitro against androgen and estrogen receptors and steroidogenic H295R cells, the polymer particles themselves do not strongly activate either receptor at concentrations relevant to human exposure ^[64]. The estrogenic signal in the leachate work above is not the polymer; it is what came out of the polymer.

These findings are consistent with the vector logic. The polymer scaffolding is not estrogenic in the classical sense. The material system that a microplastic represents in vivo (i.e., polymer plus additives plus sorbed contaminants plus weathering products) is.

Androgen pathway and testosterone

The androgen story diverges from the estrogen story in one important way: some of the effects appear to be driven by the particle itself, through mechanisms that do not require an additive.

In male mice, chronic exposure to polystyrene microplastics reduces sperm quality, damages testicular architecture, and lowers serum testosterone through a defined pathway: microplastic uptake in the testis, oxidative stress, activation of p38 MAPK, and disruption of the LH → LHR → cAMP → PKA → StAR signaling axis that controls testosterone synthesis in Leydig cells ^[65-68]. Related work identifies HIF-1α activation via ERK1/2 MAPK and AKT as a further mechanism by which polystyrene nanoplastics suppress StAR expression in TM3 Leydig cells and testicular tissue ^[69], and NF-κB signaling as a route to LHR reduction and testosterone decline under chronic exposure ^[70]. Independent replications converge on the same axis from different starting points: chronic polystyrene exposure reduces testosterone via mitochondrial oxidative stress and BAX/BCL2-mediated apoptosis in mouse spermatogenic cells ^[71], spermatogonium mitochondrial oxidative stress and apoptosis under short-term polystyrene exposure ^[72], and p53-mediated apoptosis of spermatogenic cells in male mice ^[73]. The effect is not limited to polystyrene: polyamide microplastics reduce testosterone bioavailability through adsorption behavior ^[74], and polylactic acid — sometimes marketed as a safer bioplastic — induces male reproductive toxicity via disrupted spermatogenesis and mitochondrial dysfunction ^[75]. In cultured Leydig cells, nanoplastic exposure damages mitochondria and destroys cell membranes ^[76], and combined Leydig-plus-Sertoli exposure produces mitochondrial and endoplasmic reticulum stress in both cell types ^[77]. Endogenous hydrogen sulfide can partially rescue polystyrene nanoplastic-induced mitochondrial apoptosis and autophagy in mouse spermatocyte-derived cells via Nrf2 and PGC-1α signaling, confirming the mechanism through pharmacological reversal ^[78].

The particle also disrupts the blood-testis barrier itself, the structure that normally shields developing sperm from systemic exposure. Polystyrene microplastics disrupt blood-testis barrier integrity through ROS-mediated imbalance of mTORC1 and mTORC2 ^[79], with independent replication showing the same barrier disruption regulated by MAPK-Nrf2 signaling in rats ^[80]. Once the barrier is compromised, particles and their chemical passengers have easier access to spermatogenic tissue.

Meta-analysis of 39 studies constructs an adverse outcome pathway centered on reactive oxygen species leading to steroidogenic disruption and reduced sperm quality ^[81]. Orally administered fluorescent nanosized polystyrene alters hormonal and inflammatory profiles and behavior in treated mice ^[82]. Male rats exposed orally to polystyrene nanoplastics for five weeks showed reduced serum testosterone, LH, and FSH, sperm DNA damage, and altered testicular gene expression ^[83]. Co-exposure with cadmium worsened rat testicular activity, again more than either alone ^[84]. Prenatal and postnatal polystyrene exposure disrupted testicular development and reduced adult fertility in mice ^[85].

Importantly, several of these studies use highly purified polystyrene with low residual additive content, meaning the testicular effect is not fully attributable to plasticizer leachate. The particle is doing endocrine work.

Female reproductive endocrine effects

The female picture is younger but converges on the same axis.

Polystyrene microplastics cause granulosa cell apoptosis and ovarian fibrosis in rats, mediated by oxidative stress ^[86], with the Keap1/Nrf2/HO-1 pathway available as a pharmacological rescue target ^[87]. Polystyrene nanoplastics accumulate in ovarian tissue in mice, cause granulosa cell death, and disrupt hormone production in both mouse ovary and human ovarian granulosa cell culture ^[88]. Nanoplastics impair swine granulosa cell function at higher doses, increasing steroid secretion alongside oxidative stress in a pattern consistent with dysregulation rather than simple suppression ^[89]. Ingested polystyrene microplastics have been shown to induce female reproductive toxicity in mice with high independent citation support ^[90]. In female mice fed microplastics for 30 days, egg quality, fertilization rates, and fertility dropped through oxidative stress and DNA damage, with reproductive consequences visible in offspring ^[91]. Low-dose exposure retards oocyte meiotic maturation through HDAC3 insufficiency and metabolic disruption in mouse oocytes ^[92]. Comparison of male and female mice under matched exposure protocols found particles accumulated more in ovaries than testes, with corresponding oxidative and reproductive damage ^[93]. Systematic review of the hypothalamic-pituitary-ovarian axis in animal models finds a consistent pattern of decreased estradiol, ovarian oxidative stress, and altered folliculogenesis ^[94].

The uterus is not exempt. Polystyrene microplastic exposure induces uterine fibrosis in mice through TLR4/NOX2 signaling, with characteristic endometrial thinning and collagen deposition ^[95]. Microplastics have now been detected in the uterine lining of women (polyamide, polyurethane, PET fragments of 2 to 200 micrometers) and mouse follow-up shows reproductive consequences of similar exposures ^[3]. Human endometrial stromal cell work is beginning to characterize the mechanisms ^[96]. Zebrafish daily-exposure work has induced ovarian fibrosis and metabolic features consistent with polycystic ovary syndrome ^[97].

At the level of the oocyte itself, polystyrene microplastics have been detected in follicular fluid from women and cows, and matched in vitro exposure of bovine oocytes compromises their developmental competence ^[4]. Independent 2025 sampling of human ovarian follicular fluid provides the first stand-alone replication of the follicular-fluid detection finding, framed explicitly as an emerging fertility concern ^[98]. Systematic reviews of nanoplastic exposure to the neuroendocrine control of reproduction now report that GnRH neurons are functionally impaired by polystyrene nanoplastic exposure in vitro, including altered migration and neuroendocrine secretion ^[99].

The female axis, like the male axis, seems to be perturbed by particles as well as by additives.

Placenta and pregnancy

The placenta is where the particle-and-chemical stories collide most directly, because the placenta is both a barrier and an endocrine organ.

Polystyrene nanoplastics activate autophagy in trophoblast cells, suppress migration and invasion, and disrupt migrasome formation sufficiently enough to induce miscarriage in mice at doses within an order of magnitude of estimated human exposure ^[100]. In vitro exposure of human trophoblasts to 100 nm polystyrene nanoplastics affects trophoblast function ^[101]. Exposure of primary human placental cells to polystyrene nanoparticles at concentrations found in human blood produces cytotoxicity, inflammation, and disrupted hormone production, with smaller (20 nm) particles more active than larger ones ^[102]. A physiologically relevant human placental co-culture model finds limited but nonzero particle passage across the barrier, with size-dependent functional effects ^[103]. Polystyrene microplastics disturb maternal-fetal immune balance and cause reproductive toxicity in pregnant mice, extending the placental mechanism into the systemic immunology of pregnancy ^[104]. A targeted risk-assessment framework applied to 40 placenta-relevant studies rates the reproductive risk as moderate-to-low but real ^[105]. Systematic reviews of pregnancy and early childhood exposure summarize placental transfer, transfer to breast milk and cord blood, and adverse pregnancy outcomes ^[106-107]. A 2026 review specific to placental development and pregnancy outcomes concludes that micro- and nanoplastics together with their plasticizers are a coherent developmental concern ^[108].

Placental hormone disruption is not incidental. The placenta produces progesterone, human chorionic gonadotropin, and placental lactogen. If nanoplastics change trophoblast function, they change the hormonal milieu of pregnancy, with downstream consequences for the fetus that a receptor-binding assay in a dish will not capture.

Metabolism, adipogenesis, and the obesogen frame

Obesogens are EDCs that promote adipogenesis or adipocyte hypertrophy. BPA, several phthalates, and PFAS are the canonical examples, and the umbrella evidence for their metabolic effects at population exposure is now substantial ^[9,109]. The microplastic literature intersects here in two ways.

First, the reviews reframe microplastics themselves as an obesogenic exposure class, arguing that the particles, their additives, and their sorbed contaminants collectively contribute to metabolic dysregulation ^[32,110]. Second, mechanistic and mixed-exposure work is starting to sketch the pathways: polystyrene microplastics in drinking water induced PCOS-like features in female zebrafish, with insulin resistance and ovarian fibrosis alongside hormone imbalance ^[97]; environmental EDC exposure has been argued to warrant recognition as a risk factor for type 2 diabetes ^[111]; medical infusion solutions themselves have been shown to contain micro- and nanoplastics together with phthalates, with measurable cardiovascular cytotoxicity implications ^[112]. Repeated exposure of THP-1 macrophages to polyethylene microplastic mixtures containing PFAS and bisphenols activated inflammatory features not seen with the particle alone; an immunometabolic axis that likely modulates any endocrine outcome downstream ^[113]. And a large panel of micro- and nanoplastics tested against THP-1 macrophages shows differential activation of the NLRP3 inflammasome depending on polymer, size, and surface chemistry; a mechanistic bridge between particle exposure and the chronic low-grade inflammation that underlies obesogenic and metabolic disease ^[114].

Transgenerational effects

Reproductive endocrine effects that persist in unexposed offspring are a defining feature of many known EDCs. The microplastic literature is beginning to show similar patterns. Long term nanoplastic exposure in C. elegans produces multi- and transgenerational reproductive decline associated with germline toxicity and epigenetic regulation ^[115]. Polystyrene nanoplastic exposure in C. elegans produces transgenerational reproductive toxicity through enhanced DNA damage and DNA repair inhibition ^[116]. Synergistic transgenerational reproductive toxicity of polystyrene nanoplastics and butylparaben, a common plastic-associated chemical, is documented at otherwise “real world” level doses ^[117]. In marine medaka, microplastics cause sex-specific reproductive disruption and transgenerational effects ^[118], and increase ovarian phenanthrene accumulation with transgenerational toxicity downstream ^[119]. Polystyrene microplastics induced male reproductive toxicity and transgenerational effects in freshwater prawn ^[120]. And soil-digested microplastics produce nanoplastic fragments that damage earthworm spermatogenesis ^[121].

These are invertebrate and fish studies. They are not proof that human transgenerational endocrine effects exist. They are proof that the mechanisms known to produce transgenerational endocrine effects in other systems are triggered by microplastic exposure in models where transgenerational endpoints can be measured.

Human evidence

Human evidence is the layer where honest uncertainty is largest. The particles are present in human tissues. The chemicals are present in human biomonitoring. The endocrine outcomes are present in human populations. The direct causal chain from microplastic burden to a specific endocrine outcome in a specific person has not been drawn.

What exists at the human level is roughly this. Microplastics have been quantified in blood in 90% of a small volunteer sample, with 24 distinct polymer types identified ^[1]. Microplastics have been detected in six of ten semen samples from men in a polluted southern Italian region ^[2], and are the subject of a review arguing they may be a significant contributor to the decades-long decline in male fertility ^[122]. A 2025 mammalian-fertility systematic review and meta-analysis compiles the animal reproductive data alongside the emerging human evidence ^[123]. Uterine microplastics have been documented in 22 women with mouse follow-up showing corresponding reproductive damage ^[3]. Follicular fluid in women and cows contains microplastics, with matched in vitro exposure of oocytes showing functional compromise ^[4], and this finding has been independently replicated in a 2025 human ovarian follicular fluid cohort ^[98]. Microplastics have been detected in human lung tissue by μFTIR ^[5], in three types of human artery by pyrolysis-GC/MS ^[6] and in saphenous vein tissue in a pilot study ^[124], and in human feces at levels correlated with inflammatory bowel disease status ^[7]. Placental and perinatal detection is now sufficiently common that systematic reviews of pregnancy and early-childhood outcomes are being written ^[8,106-107], alongside broader systematic reviews of human tissue accumulation across organ systems ^[125] and state-of-the-art reviews of MP exposure, detection, and downstream risk including carcinogenesis ^[126]. Human dietary exposure is characterized across water, salt, seafood, packaged food, and alcoholic beverages ^[127]. Pediatric cohort meta-analysis links phthalate exposure to shifted thyroid hormones ^[39]. Umbrella reviews of BPA, phthalates, and PFAS link these plastic-associated chemicals to reproductive, metabolic, and thyroid disease at population exposures ^[9,128-129]. A cross-organ endocrine review focused on functional and clinical human exposure from marine microplastics adds a second synthesis at the endocrine-clinical layer ^[130]. A general review of potential human health impacts of MP/NP exposure provides the widely cited framing reference ^[131]. An early human-exposure biomonitoring study in Iran quantified skin, hair, and saliva burdens across two thousand adults ^[132].

What does not yet exist is the study that measures microplastic burden and hormonal status in the same individuals across a large cohort, adjusts for the co-exposed chemicals, and shows a dose-response. When that study arrives, the evidence tier will change. Until then, the human layer supports "biologically plausible and quantitatively concerning" rather than "epidemiologically established."

Methodological limitations

Any reader of this literature has to keep several caveats close.

Particle standards. The overwhelming majority of animal and in vitro work uses polystyrene, often uniform spheres, often from a single vendor. Real environmental microplastics are heterogeneous fragments, fibers, and films, mostly polyethylene, polypropylene, and PET, with variable weathering and additive loads ^[127,133]. Effect estimates from polystyrene spheres do not translate one-to-one, and the more careful current framings treat microplastics as a diverse contaminant suite rather than a single tractable exposure ^[19].

Dose. Many rodent studies use exposures well above estimated human ingestion. Some are now using environmentally realistic doses and still finding effects, especially for reproductive endpoints and for co-exposures with additives ^{[92-93,100,117]}. Others explicitly report negligible transgenerational effects when parental exposure is set at environmentally relevant concentrations ^[134], and secondary PET microplastic exposure at realistic environmental doses produces biochemical responses of modest magnitude in freshwater amphipods ^[135]. The gradient of biological effect versus dose is not fully mapped.

Additive versus particle attribution. The additive contribution to observed effects is real and, in many studies, dominant. Virgin polymer studies are the cleanest test of particle-only effects; several exist and do show effects, particularly for oxidative stress and reproductive toxicity ^[136], but they are outnumbered by studies where additives cannot be excluded. Direct receptor-activity assays are important here: polystyrene micro- and nanoplastics tested in vitro do not strongly activate androgen or estrogen receptors on their own, which puts an upper bound on the "polymer is estrogenic" reading of the vector-effect literature ^[64].

Vector effect and physiological chemistry. Enhanced desorption under gut conditions changes what a particle actually delivers to the body compared to what it carries in the environment ^[15-16]. Aged particles behave differently from fresh ones ^[23,28,137], and comparisons of DEHP adsorption to pristine versus aged polystyrene in seawater confirm that pristine-polymer studies do not predict aged-polymer behavior ^[138]. Real-world exposure is to weathered, additive-carrying, contaminant-sorbing mixed-polymer particles, not to research-grade spheres, and even standard oxidative-stress endpoints in algae respond differently to pristine versus aged particles and their leachates ^[139].

Human tissue detection. Analytical methods for microplastics in tissue still vary in sensitivity and specificity. Not all detection reports have been independently replicated. Contamination during collection is a live issue — a 2026 critical review of blood storage bag materials documents packaging-induced polymer deterioration that can plausibly contaminate blood-based microplastic measurements ^[140]. The direction of travel is clear, but the numerical estimates should be treated with appropriate humility. A recent systematic review of mechanisms, biomarkers, and clinical outcomes makes the same point: most of the mechanistic weight is still preclinical ^[128].

Confounding. In humans, microplastic exposure correlates with BPA exposure, phthalate exposure, PFAS exposure, dietary pattern, socioeconomic status, and geography. Disentangling particle effects from additive effects in observational data is genuinely hard, and no cohort has yet done it well. The synthesis review that separates experimental from human evidence most explicitly is a useful anchor for readers who want to see where the human tier actually stops ^[8].

Synthesis

The best current reading of the evidence is that microplastics contribute to endocrine disruption through at least three distinguishable mechanisms that operate simultaneously.

The first and best-supported is chemical carriage. Bisphenols, phthalates, alkylphenols, brominated flame retardants, and sorbed environmental contaminants are known endocrine disruptors on their own terms; microplastics change how much of each reaches tissue, how the exposure is timed, and where it lands. This mechanism is dominant at the population level for BPA, phthalates, and PFAS-type outcomes, and it is where the human epidemiology is strongest ^[9,52].

The second is particle-driven perturbation of steroidogenic and gametogenic cells. Purified polystyrene particles reach the testis and ovary in rodents, are internalized by Leydig, Sertoli, and granulosa cells, and disrupt the LH → LHR → cAMP → PKA → StAR axis and the ovarian oxidative environment through oxidative stress, mitochondrial damage, and inflammatory signaling ^[81,141,94]. These effects do not require an additive leachate. They are not yet quantified in humans, but the mechanistic burden of proof for their existence in mammalian systems is now heavy.

The third is placental and gestational effects, where particle uptake by trophoblasts changes the hormonal environment of pregnancy, and where the smallest nanoplastics do the most work ^{[100,102,103,106]}.

Sitting alongside all three is an emerging thyroid signal, driven mostly by co-exposure between microplastics and the small-molecule EDCs they carry ^{[53,54,55,38,39]}, and a metabolic/obesogenic frame that overlays the whole system ^{[32,111,110,109]}.

The right posture is not "microplastics are or are not endocrine disruptors." It is: microplastics behave, in a biological system, as a particle-plus-chemical delivery system whose endocrine consequences depend on which mechanism you are asking about. For BPA and phthalates, the particle is a carrier. For testicular and ovarian steroidogenesis, the particle is a direct actor. For placental function, both are true at once.

Where this leaves us

Microplastics act on the endocrine system in more than one way, and the strongest single lever is the chemical passenger, not the polymer itself. That does not make the polymer irrelevant. The polymer determines what chemicals are carried, how much reaches tissue, and where in the body the exposure is concentrated. It also produces its own effects on reproductive tissue, at least in animal models, that are not accounted for by the additives alone.

The cleanest interpretation is that the particle and the chemistry are not competing explanations. They are the same exposure at different resolutions. Any intervention that reduces internal exposure to either one is, by construction, reducing exposure to the other.

Winnow works upstream of both. Our probiotic strains have been shown in laboratory testing to bind micro- and nanoplastics. It is a narrow intervention point. But that point is where the particle, its passengers, and the endocrine system have not yet met.